Paper11297486
Risk factors for age-related macular degeneration: Pooled findings from three continents.
Smith W and 9 others. Ophthalmology, 2001. Cited by 825 papers, by iCite.
Cite this record
ConductScience Library. Risk factors for age-related macular degeneration: Pooled findings from three continents. Papers, record 11297486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11297486
- Disease
- wet macular degeneration55 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Risk factors for age-related macular degeneration: Pooled findings from three continents.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Macular Degeneration | Major topic |
| Adult | |
| Age Distribution | |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Netherlands | |
| New South Wales | |
| Prevalence | |
| Risk Factors | |
| Sex Distribution | |
| Smoking | |
| Wisconsin |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02810808 | Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMD | Background | ClinicalTrials.gov | |
| NCT03326401 | The Potential Role of Dietary Antioxidant Capacity on Age-Related Macular Degeneration | Results | ClinicalTrials.gov | |
| NCT05269966 | Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) | Results | ClinicalTrials.gov |
Cited by418
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 825 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42706530 | Retinal and choroidal morphometric analysis in fellow eye of unilateral wet age related macular degeneration using optical coherence tomography angiography. | BMC Ophthalmol | 2026 | https://conductscience.org/library/papers/42706530 | PubMed |
| 42332292 | Impaired Rod-Mediated Vision is the Functional Hallmark of Ageing and Early and Intermediate Age-Related Macular Degeneration. | Ophthalmic Physiol Opt | 2026 | https://conductscience.org/library/papers/42332292 | PubMed |
| 42222588 | Geographic Atrophy in Patients with Age-Related Macular Degeneration Is Associated with Rare Variants in Complement Factor H and Complement Factor I. | Ophthalmol Sci | 2026 | https://conductscience.org/library/papers/42222588 | PubMed |
| 42196841 | The Role of Kynurenine and 5-Hydroxytryptophan in Modulating Microbiota and Their Implications in Exudative Age-Related Macular Degeneration. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42196841 | PubMed |
| 42081160 | The aging eye: navigating molecular mechanisms and innovative interventions. | Biogerontology | 2026 | https://conductscience.org/library/papers/42081160 | PubMed |
| 42022797 | Frequency and comorbidities of age-related macular degeneration in KSA: A retrospective multiregional study. | J Taibah Univ Med Sci | 2026 | https://conductscience.org/library/papers/42022797 | PubMed |
| 41896965 | Simulation of prosthetic vision with the PRIMA system and enhancement of face representation. | J Neuroeng Rehabil | 2026 | https://conductscience.org/library/papers/41896965 | PubMed |
| 41794975 | Integrating genetics, age and imaging to predict treatment outcomes in neovascular age-related macular degeneration: a proof-of-concept study. | Sci Rep | 2026 | https://conductscience.org/library/papers/41794975 | PubMed |
| 41790719 | Efficacy of a single dose switch from aflibercept to ranibizumab in the treatment of neovascular age-related macular degeneration. | PLoS One | 2026 | https://conductscience.org/library/papers/41790719 | PubMed |
| 41684578 | Age-related macular degeneration in the context of an update from the Global Burden of Disease Study 2019. | Arch Med Sci | 2025 | https://conductscience.org/library/papers/41684578 | PubMed |
| 41222198 | Disease Progression in Age-Related Macular Degeneration Patients Carrying Rare Variants in the Complement Factor H or Complement Factor I Genes. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/41222198 | PubMed |
| 41181297 | Markedly Lower Rates of Age-Related Macular Degeneration in Malta Compared to European Countries: Results from The Malta Eye Study, Indicating Possible Divergent Genetic Ancestry? | Clin Ophthalmol | 2025 | https://conductscience.org/library/papers/41181297 | PubMed |
| 41177553 | Comparative outcomes of aflibercept biosimilars and reference aflibercept in nAMD: a systematic review and meta-analysis. | BMJ Open Ophthalmol | 2025 | https://conductscience.org/library/papers/41177553 | PubMed |
| 41160616 | Association of perchlorate, nitrate, and thiocyanate with age-related macular degeneration in the United States. | PLoS One | 2025 | https://conductscience.org/library/papers/41160616 | PubMed |
| 41055418 | Perceptual learning of prosthetic vision using video game training. | J Vis | 2025 | https://conductscience.org/library/papers/41055418 | PubMed |
| 40960227 | Reshaping the Burden of nAMD: National, Regional, and Global Prevalence of MNV3 and Its Correlation With Life Expectancy-The RAP Study, Report 7. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40960227 | PubMed |
| 40925399 | Amorphous silicon resistors enable smaller pixels in photovoltaic retinal prosthesis. | J Neural Eng | 2025 | https://conductscience.org/library/papers/40925399 | PubMed |
| 40806731 | Epigenetic Alterations in Age-Related Macular Degeneration: Mechanisms and Implications. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806731 | PubMed |
| 40794636 | Unveiling the drivers of geographic atrophy progression in eyes with reticular pseudodrusen. | PLoS One | 2025 | https://conductscience.org/library/papers/40794636 | PubMed |
| 40781266 | Association between age-related macular degeneration and osteoporosis in US. | Sci Rep | 2025 | https://conductscience.org/library/papers/40781266 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| BROLUCIZUMAB | CHEMBL3707357 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL3707357 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11297486
GET https://conductscience.org/api/papers/v1/11297486/cited_by?page=2